T0	Participants 70 104	healthy and hypertensive subjects:
T1	Participants 214 269	normal humans and patients with essential hypertension.
T2	Participants 449 494	healthy subjects and in hypertensive patients
T3	Participants 629 733	11 healthy subjects (controls) and 12 hypertensive inpatients (mean age, 38.9 and 40.4 yr, respectively)